Clinical grade iPS cells: Need for versatile small molecules and optimal cell sources

Chemistry and Biology

Volumn 20, Issue 11, 2013, Pages 1311-1322

  Wu, Yan Ling ^a   Pandian, Ganesh N ^b   Ding, Yan Ping ^a   Zhang, Wen ^c   Tanaka, Yoshimasa ^d   Sugiyama, Hiroshi ^b,d  

^a ZHEJIANG PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b KYOTO UNIVERSITY   (Japan)

^c ZHEJIANG UNIVERSITY OF TECHNOLOGY   (China)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; ASCORBIC ACID; BAYK 8644; BUTYRIC ACID; CALCIUM CHANNEL STIMULATING AGENT; CHIR 99021; DNA METHYLTRANSFERASE; FORSKOLIN; GLYCOGEN SYNTHASE KINASE 3; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; IMIDAZOLE DERIVATIVE; KRUPPEL LIKE FACTOR 4; LITHIUM; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MYC PROTEIN; N (1 BENZYL 4 PIPERIDINYL) 2 (HEXAHYDRO 4 METHYL 1H 1,4 DIAZEPIN 1 YL) 6,7 DIMETHOXY 4 QUINAZOLINAMINE; N (2,3 DIHYDROXYPROPOXY) 3,4 DIFLUORO 2 (2 FLUORO 4 IODOANILINO)BENZAMIDE; OCTAMER TRANSCRIPTION FACTOR 4; PYRROLE DERIVATIVE; PYRROLE IMIDAZOLE POLYAMIDE; RAPAMYCIN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TRICHOSTATIN A; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID; VORINOSTAT;

AMNION CELL; BIOTECHNOLOGY; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINE; CELL REGENERATION; CELL TYPE; COPY NUMBER VARIATION; DEMETHYLATION; EMBRYONIC STEM CELL; ENZYME INHIBITION; FIBROBLAST; GENE EXPRESSION; GENE TARGETING; GENETIC MANIPULATION; HEMATOPOIETIC CELL; HOSPITAL; HUMAN; LABORATORY; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; MOLECULE; NEURAL STEM CELL; NONHUMAN; NUCLEAR REPROGRAMMING; OOCYTE; OSMOSIS; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RETROVIRUS; REVIEW; RNA SYNTHESIS; SCIENTIST; SOMATIC CELL; TRANSPOSON; TUMOR CELL; UMBILICAL VEIN ENDOTHELIAL CELL; WOUND HEALING; ANIMAL; CYTOLOGY; DRUG EFFECTS; INDUCED PLURIPOTENT STEM CELL; METABOLISM; STANDARDS; TRANSLATIONAL RESEARCH; TRANSPLANTATION;

ANIMALS; CELLULAR REPROGRAMMING; HUMANS; INDUCED PLURIPOTENT STEM CELLS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84888263841     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2013.09.016     Document Type: Review

References (98)

1. T. Aasen, A. Raya, M.J. Barrero, E. Garreta, A. Consiglio, F. Gonzalez, R. Vassena, J. Bilić, V. Pekarik, and G. Tiscornia Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes Nat. Biotechnol. 26 2008 1276 1284
2. A. Abyzov, J. Mariani, D. Palejev, Y. Zhang, M.S. Haney, L. Tomasini, A.F. Ferrandino, L.A. Rosenberg Belmaker, A. Szekely, and M. Wilson Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells Nature 492 2012 438 442
3. R.M. Anchan, P. Quaas, B. Gerami-Naini, H. Bartake, A. Griffin, Y. Zhou, D. Day, J.L. Eaton, L.L. George, and C. Naber Amniocytes can serve a dual function as a source of iPS cells and feeder layers Hum. Mol. Genet. 20 2011 962 974
4. F. Anokye-Danso, C.M. Trivedi, D. Juhr, M. Gupta, Z. Cui, Y. Tian, Y. Zhang, W. Yang, P.J. Gruber, J.A. Epstein, and E.E. Morrisey Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency Cell Stem Cell 8 2011 376 388
5. R. Araki, M. Uda, Y. Hoki, M. Sunayama, M. Nakamura, S. Ando, M. Sugiura, H. Ideno, A. Shimada, A. Nifuji, and M. Abe Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells Nature 494 2013 100 104
6. H. Ban, N. Nishishita, N. Fusaki, T. Tabata, K. Saeki, M. Shikamura, N. Takada, M. Inoue, M. Hasegawa, S. Kawamata, and S. Nishikawa Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors Proc. Natl. Acad. Sci. USA 108 2011 14234 14239
7. B. Barrilleaux, and P.S. Knoepfler Inducing iPSCs to escape the dish Cell Stem Cell 9 2011 103 111
8. U. Ben-David, Q.-F. Gan, T. Golan-Lev, P. Arora, O. Yanuka, Y.S. Oren, A. Leikin-Frenkel, M. Graf, R. Garippa, and M. Boehringer Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen Cell Stem Cell 12 2013 167 179
9. R. Briggs, and T.J. King Transplantation of living nuclei from blastula cells into enucleated frogs' eggs Proc. Natl. Acad. Sci. USA 38 1952 455 463
10. T. Chen, D. Yuan, B. Wei, J. Jiang, J. Kang, K. Ling, Y. Gu, J. Li, L. Xiao, and G. Pei E-cadherin-mediated cell-cell contact is critical for induced pluripotent stem cell generation Stem Cells 28 2010 1315 1325
11. T. Chen, L. Shen, J. Yu, H. Wan, A. Guo, J. Chen, Y. Long, J. Zhao, and G. Pei Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells Aging Cell 10 2011 908 911
12. D. Cyranoski Stem cells cruise to clinic: Japanese study of induced pluripotent stem cells aims to demonstrate safety in humans Nature 494 2013 413
13. R.L. Davis, H. Weintraub, and A.B. Lassar Expression of a single transfected cDNA converts fibroblasts to myoblasts Cell 51 1987 987 1000
14. H. Egusa, K. Okita, H. Kayashima, G. Yu, S. Fukuyasu, M. Saeki, T. Matsumoto, S. Yamanaka, and H. Yatani Gingival fibroblasts as a promising source of induced pluripotent stem cells PLoS ONE 5 2010 e12743
15. M.A. Esteban, T. Wang, B. Qin, J. Yang, D. Qin, J. Cai, W. Li, Z. Weng, J. Chen, and S. Ni Vitamin C enhances the generation of mouse and human induced pluripotent stem cells Cell Stem Cell 6 2010 71 79
16. M.J. Evans, and M.H. Kaufman Establishment in culture of pluripotential cells from mouse embryos Nature 292 1981 154 156
17. Y. Feng, Y. Yin, A. Weiser, E. Griffin, M.D. Cameron, L. Lin, C. Ruiz, S.C. Schürer, T. Inoue, and P.V. Rao Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors J. Med. Chem. 51 2008 6642 6645
18. A.G. Fisher, and M. Merkenschlager Fresh powder on Waddington's slopes EMBO Rep. 11 2010 490 492
19. J.M. Gimble, A.J. Katz, and B.A. Bunnell Adipose-derived stem cells for regenerative medicine Circ. Res. 100 2007 1249 1260
20. A. Giorgetti, N. Montserrat, T. Aasen, F. Gonzalez, I. Rodríguez-Pizà, R. Vassena, A. Raya, S. Boué, M.J. Barrero, and B.A. Corbella Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2 Cell Stem Cell 5 2009 353 357
21. A. Gore, Z. Li, H.L. Fung, J.E. Young, S. Agarwal, J. Antosiewicz-Bourget, I. Canto, A. Giorgetti, M.A. Israel, and E. Kiskinis Somatic coding mutations in human induced pluripotent stem cells Nature 471 2011 63 67
22. J.B. Gurdon The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles J. Embryol. Exp. Morphol. 10 1962 622 640
23. I. Gutierrez-Aranda, V. Ramos-Mejia, C. Bueno, M. Munoz-Lopez, P.J. Real, A. Mácia, L. Sanchez, G. Ligero, J.L. Garcia-Parez, and P. Menendez Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection Stem Cells 28 2010 1568 1570
24. L. Han, G.N. Pandian, S. Junetha, S. Sato, C. Anandhakumar, J. Taniguchi, A. Saha, T. Bando, H. Nagase, and H. Sugiyama A synthetic small molecule for targeted transcriptional activation of germ cell genes in a human somatic cell Angew. Chem. Int. Ed. 2013 10.1002/anie.20130676 Published online October 18, 2013
25. M.E. Hester, S. Song, C.J. Miranda, A. Eagle, P.H. Schwartz, and B.K. Kaspar Two factor reprogramming of human neural stem cells into pluripotency PLoS ONE 4 2009 e7044
26. H. Hirai, T. Tani, N. Katoku-Kikyo, S. Kellner, P. Karian, M. Firpo, and N. Kikyo Radical acceleration of nuclear reprogramming by chromatin remodeling with the transactivation domain of MyoD Stem Cells 29 2011 1349 1361
27. A. Hotta, A.Y.L. Cheung, N. Farra, K. Vijayaragavan, C.A. Séguin, J.S. Draper, P. Pasceri, I.A. Maksakova, D.L. Mager, and J. Rossant Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency Nat. Methods 6 2009 370 376
28. P. Hou, Y. Li, X. Zhang, C. Liu, J. Guan, H. Li, T. Zhao, J. Ye, W. Yang, and K. Liu Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds Science 341 2013 651 654
29. D. Huangfu, R. Maehr, W. Guo, A. Eijkelenboom, M. Snitow, A.E. Chen, and D.A. Melton Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds Nat. Biotechnol. 26 2008 795 797
30. S.M. Hussein, N.N. Batada, S. Vuoristo, R.W. Ching, R. Autio, E. Närvä, S. Ng, M. Sourour, R. Hämäläinen, and C. Olsson Copy number variation and selection during reprogramming to pluripotency Nature 471 2011 58 62
31. G. Kashiwazaki, T. Bando, T. Yoshidome, S. Masui, T. Takagaki, K. Hashiya, G.N. Pandian, J. Yasuoka, K. Akiyoshi, and H. Sugiyama Synthesis and biological properties of highly sequence-specific-alkylating N-methylpyrrole-N-methylimidazole polyamide conjugates J. Med. Chem. 55 2012 2057 2066
32. T. Kawamura, J. Suzuki, Y.V. Wang, S. Menendez, L.B. Morera, A. Raya, G.M. Wahl, and J.C. Izpisúa Belmonte Linking the p53 tumour suppressor pathway to somatic cell reprogramming Nature 460 2009 1140 1144
33. B.L. Kidder, and S. Palmer HDAC1 regulates pluripotency and lineage specific transcriptional networks in embryonic and trophoblast stem cells Nucleic Acids Res. 40 2012 2925 2939
34. J.B. Kim, H. Zaehres, G. Wu, L. Gentile, K. Ko, V. Sebastiano, M.J. Araúzo-Bravo, D. Ruau, D.W. Han, M. Zenke, and H.R. Schöler Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors Nature 454 2008 646 650
35. D. Kim, C.-H. Kim, J.-I. Moon, Y.-G. Chung, M.-Y. Chang, B.-S. Han, S. Ko, E. Yang, K.Y. Cha, R. Lanza, and K.S. Kim Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins Cell Stem Cell 4 2009 472 476
36. K. Kim, A. Doi, B. Wen, K. Ng, R. Zhao, P. Cahan, J. Kim, M.J. Aryee, H. Ji, and L.I.R. Ehrlich Epigenetic memory in induced pluripotent stem cells Nature 467 2010 285 290
37. S. Kishigami, E. Mizutani, H. Ohta, T. Hikichi, N.V. Thuan, S. Wakayama, H.-T. Bui, and T. Wakayama Significant improvement of mouse cloning technique by treatment with trichostatin A after somatic nuclear transfer Biochem. Biophys. Res. Commun. 340 2006 183 189
38. L.J. Kleinsmith, and G.B. Pierce Jr. Multipotentiality of single embryonal carcinoma cells Cancer Res. 24 1964 1544 1551
39. J. Lee, N. Sayed, A. Hunter, K.F. Au, W.H. Wong, E.S. Mocarski, R.R. Pera, E. Yakubov, and J.P. Cooke Activation of innate immunity is required for efficient nuclear reprogramming Cell 151 2012 547 558
40. W. Li, H. Zhou, R. Abujarour, S. Zhu, J. Young Joo, T. Lin, E. Hao, H.R. Schöler, A. Hayek, and S. Ding Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2 Stem Cells 27 2009 2992 3000
41. Y. Li, Q. Zhang, X. Yin, W. Yang, Y. Du, P. Hou, J. Ge, C. Liu, W. Zhang, and X. Zhang Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules Cell Res. 21 2011 196 204
42. W. Li, E. Tian, Z.-X. Chen, G. Sun, P. Ye, S. Yang, D. Lu, J. Xie, T.-V. Ho, and W.M. Tsark Identification of Oct4-activating compounds that enhance reprogramming efficiency Proc. Natl. Acad. Sci. USA 109 2012 20853 20858
43. G. Liang, O. Taranova, K. Xia, and Y. Zhang Butyrate promotes induced pluripotent stem cell generation J. Biol. Chem. 285 2010 25516 25521
44. T. Lin, R. Ambasudhan, X. Yuan, W. Li, S. Hilcove, R. Abujarour, X. Lin, H.S. Hahm, E. Hao, A. Hayek, and S. Ding A chemical platform for improved induction of human iPSCs Nat. Methods 6 2009 805 808
45. R. Lister, M. Pelizzola, Y.S. Kida, R.D. Hawkins, J.R. Nery, G. Hon, J. Antosiewicz-Bourget, R. O'Malley, R. Castanon, and S. Klugman Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells Nature 471 2011 68 73
46. Y.-H. Loh, S. Agarwal, I.-H. Park, A. Urbach, H. Huo, G.C. Heffner, K. Kim, J.D. Miller, K. Ng, and G.Q. Daley Generation of induced pluripotent stem cells from human blood Blood 113 2009 5476 5479
47. C. Lu, P.S. Ward, G.S. Kapoor, D. Rohle, S. Turcan, O. Abdel-Wahab, C.R. Edwards, R. Khanin, M.E. Figueroa, and A. Melnick IDH mutation impairs histone demethylation and results in a block to cell differentiation Nature 483 2012 474 478
48. C.A. Lyssiotis, R.K. Foreman, J. Staerk, M. Garcia, D. Mathur, S. Markoulaki, J. Hanna, L.L. Lairson, B.D. Charette, and L.C. Bouchez Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4 Proc. Natl. Acad. Sci. USA 106 2009 8912 8917
49. N. Maherali, R. Sridharan, W. Xie, J. Utikal, S. Eminli, K. Arnold, M. Stadtfeld, R. Yachechko, J. Tchieu, and R. Jaenisch Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution Cell Stem Cell 1 2007 55 70
50. P. Mali, Z. Ye, H.H. Hommond, X. Yu, J. Lin, G. Chen, J. Zou, and L. Cheng Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts Stem Cells 26 2008 1998 2005
51. P. Mali, B.K. Chou, J. Yen, Z. Ye, J. Zou, S. Dowey, R.A. Brodsky, J.E. Ohm, W. Yu, and S.B. Baylin Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes Stem Cells 28 2010 713 720
52. J. Mathieu, Z. Zhang, A. Nelson, D.A. Lamba, T.A. Reh, C. Ware, and H. Ruohola-Baker Hypoxia induces re-entry of committed cells into pluripotency Stem Cells 31 2013 1737 1748 10.1002/stem.1446
53. T.S. Mikkelsen, J. Hanna, X. Zhang, M. Ku, M. Wernig, P. Schorderet, B.E. Bernstein, R. Jaenisch, E.S. Lander, and A. Meissner Dissecting direct reprogramming through integrative genomic analysis Nature 454 2008 49 55
54. M. Nakagawa, M. Koyanagi, K. Tanabe, K. Takahashi, T. Ichisaka, T. Aoi, K. Okita, Y. Mochiduki, N. Takizawa, and S. Yamanaka Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts Nat. Biotechnol. 26 2008 101 106
55. S. Ohmine, K.A. Squillace, K.A. Hartjes, M.C. Deeds, A.S. Armstrong, T. Thatava, T. Sakuma, A. Terzic, Y. Kudva, and Y. Ikeda Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency Aging (Albany, N.Y. Online) 4 2012 60 73
56. K. Okita, T. Ichisaka, and S. Yamanaka Generation of germline-competent induced pluripotent stem cells Nature 448 2007 313 317
57. K. Okita, M. Nakagawa, H. Hyenjong, T. Ichisaka, and S. Yamanaka Generation of mouse induced pluripotent stem cells without viral vectors Science 322 2008 949 953
58. K. Okita, Y. Matsumura, Y. Sato, A. Okada, A. Morizane, S. Okamoto, H. Hong, M. Nakagawa, K. Tanabe, and K. Tezuka A more efficient method to generate integration-free human iPS cells Nat. Methods 8 2011 409 412
59. T.T. Onder, N. Kara, A. Cherry, A.U. Sinha, N. Zhu, K.M. Bernt, P. Cahan, B.O. Marcarci, J. Unternaehrer, and P.B. Gupta Chromatin-modifying enzymes as modulators of reprogramming Nature 483 2012 598 602
60. G.N. Pandian, and H. Sugiyama Programmable genetic switches to control transcriptional machinery of pluripotency Biotechnol. J. 7 2012 798 809
61. G.N. Pandian, and H. Sugiyama Strategies to modulate heritable epigenetic defects in cellular machinery: lessons from nature Pharmaceuticals 6 2013 1 24
62. G.N. Pandian, K. Shinohara, A. Ohtsuki, Y. Nakano, M. Masafumi, T. Bando, H. Nagase, Y. Yamada, A. Watanabe, and N. Terada Synthetic small molecules for epigenetic activation of pluripotency genes in mouse embryonic fibroblasts ChemBioChem 12 2011 2822 2828
63. G.N. Pandian, Y. Nakano, S. Sato, H. Morinaga, T. Bando, H. Nagase, and H. Sugiyama A synthetic small molecule for rapid induction of multiple pluripotency genes in mouse embryonic fibroblasts Sci. Rep. 2 2012 544
64. G.N. Pandian, A. Ohtsuki, T. Bando, S. Sato, K. Hashiya, and H. Sugiyama Development of programmable small DNA-binding molecules with epigenetic activity for induction of core pluripotency genes Bioorg. Med. Chem. 20 2012 2656 2660
65. A.D. Panopoulos, S. Ruiz, F. Yi, A. Herrerías, E.M. Batchelder, and J.C. Izpisua Belmonte Rapid and highly efficient generation of induced pluripotent stem cells from human umbilical vein endothelial cells PLoS ONE 6 2011 e19743
66. I.-H. Park, R. Zhao, J.A. West, A. Yabuuchi, H. Huo, T.A. Ince, P.H. Lerou, M.W. Lensch, and G.Q. Daley Reprogramming of human somatic cells to pluripotency with defined factors Nature 451 2008 141 146
67. J.M. Polo, and K. Hochedlinger When fibroblasts MET iPSCs Cell Stem Cell 7 2010 5 6
68. A. Raya, I. Rodríguez-Pizà, G. Guenechea, R. Vassena, S. Navarro, M.J. Barrero, A. Consiglio, M. Castellà, P. Río, and E. Sleep Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells Nature 460 2009 53 59
69. A. Saha, G.N. Pandian, S. Sato, J. Taniguchi, K. Hashiya, T. Bando, and H. Sugiyama Synthesis and biological evaluation of a targeted DNA-binding transcriptional activator with HDAC8 inhibitory activity Bioorg. Med. Chem. 21 2013 4201 4209
70. T. Seki, S. Yuasa, M. Oda, T. Egashira, K. Yae, D. Kusumoto, H. Nakata, S. Tohyama, H. Hashimoto, and M. Kodaira Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells Cell Stem Cell 7 2010 11 14
71. Y. Shi, C. Desponts, J.T. Do, H.S. Hahm, H.R. Schöler, and S. Ding Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds Cell Stem Cell 3 2008 568 574
72. Y. Shi, J.T. Do, C. Desponts, H.S. Hahm, H.R. Schöler, and S. Ding A combined chemical and genetic approach for the generation of induced pluripotent stem cells Cell Stem Cell 2 2008 525 528
73. J. Shu, C. Wu, Y. Wu, Z. Li, S. Shao, W. Zhao, X. Tang, H. Yang, L. Shen, and X. Zuo Induction of pluripotency in mouse somatic cells with lineage specifiers Cell 153 2013 963 975
74. K. Si-Tayeb, F.K. Noto, A. Sepac, F. Sedlic, Z.J. Bosnjak, J.W. Lough, and S.A. Duncan Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors BMC Dev. Biol. 10 2010 81
75. J. Silva, O. Barrandon, J. Nichols, J. Kawaguchi, T.W. Theunissen, and A. Smith Promotion of reprogramming to ground state pluripotency by signal inhibition PLoS Biol. 6 2008 e253
76. A. Sridhar, M.M. Steward, and J.S. Meyer Nonxenogeneic growth and retinal differentiation of human induced pluripotent stem cells Stem Cells Transl. Med. 2 2013 255 264
77. M. Stadtfeld, M. Nagaya, J. Utikal, G. Weir, and K. Hochedlinger Induced pluripotent stem cells generated without viral integration Science 322 2008 945 949
78. S. Sugii, Y. Kida, W.T. Berggren, and R.M. Evans Feeder-dependent and feeder-independent iPS cell derivation from human and mouse adipose stem cells Nat. Protoc. 6 2011 346 358
79. M. Tachibana, P. Amato, M. Sparman, N.M. Gutierrez, R. Tippner-Hedges, H. Ma, E. Kang, A. Fulati, H.S. Lee, and H. Sritanaudomchai Human embryonic stem cells derived by somatic cell nuclear transfer Cell 153 2013 1228 1238
80. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676
81. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and S. Yamanaka Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872
82. O. Tsuji, K. Miura, K. Fujiyoshi, S. Momoshima, M. Nakamura, and H. Okano Cell therapy for spinal cord injury by neural stem/progenitor cells derived from iPS/ES cells Neurotherapeutics 8 2011 668 676
83. T. Vaijayanthi, T. Bando, K. Hashiya, G.N. Pandian, and H. Sugiyama Design of a new fluorescent probe: pyrrole/imidazole hairpin polyamides with pyrene conjugation at their γ-turn Bioorg. Med. Chem. 21 2013 852 855
84. T. Vaijayanthi, T. Bando, G.N. Pandian, and H. Sugiyama Progress and prospects of pyrrole-imidazole polyamide-fluorophore conjugates as sequence-selective DNA probes ChemBioChem 13 2012 2170 2185
85. Q. Wang, X. Xu, J. Li, J. Liu, H. Gu, R. Zhang, J. Chen, Y. Kuang, J. Fei, and C. Jiang Lithium, an anti-psychotic drug, greatly enhances the generation of induced pluripotent stem cells Cell Res. 21 2011 1424 1435
86. W. Wang, J. Yang, H. Liu, D. Lu, X. Chen, Z. Zenonos, L.S. Campos, R. Rad, G. Guo, and S. Zhang Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor γ and liver receptor homolog 1 Proc. Natl. Acad. Sci. USA 108 2011 18283 18288
87. L. Wang, L. Wang, W. Huang, H. Su, Y. Xue, Z. Su, B. Liao, H. Wang, X. Bao, and D. Qin Generation of integration-free neural progenitor cells from cells in human urine Nat. Methods 10 2013 84 89
88. L. Warren, P.D. Manos, T. Ahfeldt, Y.-H. Loh, H. Li, F. Lau, W. Ebina, P.K. Mandal, Z.D. Smith, and A. Meissner Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA Cell Stem Cell 7 2010 618 630
89. I. Wilmut, A.E. Schnieke, J. McWhir, A.J. Kind, and K.H.S. Campbell Viable offspring derived from fetal and adult mammalian cells Nature 385 1997 810 813
90. K. Woltjen, I.P. Michael, P. Mohseni, R. Desai, M. Mileikovsky, R. Hämäläinen, R. Cowling, W. Wang, P. Liu, and M. Gertsenstein PiggyBac transposition reprograms fibroblasts to induced pluripotent stem cells Nature 458 2009 766 770
91. X. Xu, Q. Wang, Y. Long, R. Zhang, X. Wei, M. Xing, H. Gu, and X. Xie Stress-mediated p38 activation promotes somatic cell reprogramming Cell Res. 23 2013 131 141
92. L. Ye, J.C. Chang, C. Lin, X. Sun, J. Yu, and Y.W. Kan Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases Proc. Natl. Acad. Sci. USA 106 2009 9826 9830
93. J. Yu, M.A. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget, J.L. Frane, S. Tian, J. Nie, G.A. Jonsdottir, V. Ruotti, and R. Stewart Induced pluripotent stem cell lines derived from human somatic cells Science 318 2007 1917 1920
94. J. Yu, K. Hu, K. Smuga-Otto, S. Tian, R. Stewart, I.I. Slukvin, and J.A. Thomson Human induced pluripotent stem cells free of vector and transgene sequences Science 324 2009 797 801
95. X. Yuan, H. Wan, X. Zhao, S. Zhu, Q. Zhou, and S. Ding Brief report: combined chemical treatment enables Oct4-induced reprogramming from mouse embryonic fibroblasts Stem Cells 29 2011 549 553
96. Z. Zhang, Y. Gao, A. Gordon, Z.Z. Wang, Z. Qian, and W.-S. Wu Efficient generation of fully reprogrammed human iPS cells via polycistronic retroviral vector and a new cocktail of chemical compounds PLoS ONE 6 2011 e26592
97. T. Zhao, Z.-N. Zhang, Z. Rong, and Y. Xu Immunogenicity of induced pluripotent stem cells Nature 474 2011 212 215
98. S. Zhu, W. Li, H. Zhou, W. Wei, R. Ambasudhan, T. Lin, J. Kim, K. Zhang, and S. Ding Reprogramming of human primary somatic cells by OCT4 and chemical compounds Cell Stem Cell 7 2010 651 655